This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Giulio Dondio: Innovator in Morphinoid Compounds
Introduction
Giulio Dondio is a notable inventor based in Baranzate di Bollate, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on morphinoid compounds. His research focuses on developing therapeutic agents that address various medical conditions.
Latest Patents
Dondio holds a patent for morphinoid compounds, specifically heterocycle condensed morphinoid derivatives. This patent highlights their therapeutic utility as analgesics, anti-allergic and anti-inflammatory agents, and brain cell protectants. These compounds are also relevant in treating conditions such as gastritis, diarrhea, cardiovascular and respiratory diseases, cough, mental illness, and epilepsy. Furthermore, they play a crucial role in organ preservation during transplant operations and in treating conditions typically managed with delta opioid receptor agonists. He has 1 patent to his name.
Career Highlights
Throughout his career, Giulio Dondio has demonstrated a commitment to advancing medical science through his innovative research. His work has the potential to improve the quality of life for patients suffering from various ailments. Dondio's contributions to the field of pharmacology are noteworthy and reflect his dedication to finding effective solutions for complex health issues.
Collaborations
Dondio has collaborated with esteemed colleagues such as Stephen Edward Clarke and Luca Francesco Raveglia. These partnerships have likely enriched his research and expanded the impact of his work in the pharmaceutical industry.
Conclusion
Giulio Dondio is a prominent inventor whose work on morphinoid compounds showcases his innovative spirit and dedication to improving healthcare. His contributions are significant in the realm of therapeutic agents, and his ongoing research continues to hold promise for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile